AAOI
Applied Optoelectronics, Inc.
AAOI has the edge over CPSH overall, supported by stronger fundamentals and stronger modeled upside.
CPSH
CPS Technologies Corporation
CPSH has lower modeled downside risk, despite its lower overall score.
AAOI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
AAOI's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CPSH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Weak | |
| Strong |
CPSH's balance sheet is currently strong, and its revenue and profitability are stable, but its cash flow is weak.
AAOI PE Valuation
AAOI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 18x next year's earnings.
CPSH PE Valuation
CPSH has no meaningful PE right now: it lost money over the past year.
AAOI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AAOI to return to profit, with revenue growing. However, they disagree widely on these estimates.
CPSH Forward outlook
There aren't enough analyst estimates for CPSH to show an outlook.
AAOI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.98 | — |
| Q3 2026 | -$0.42 | +$3.02 |
| Q2 2026 | -$0.77 | +$2.81 |
| Q1 2026 | -$0.65 | +$3.43 |
| Q4 2025 | -$0.64 | +$3.86 |
| Q3 2025 | -$3.44 | -$1.41 |
| Q2 2025 | -$3.58 | -$1.70 |
| Q1 2025 | -$4.08 | -$2.29 |
| Q4 2024 | -$4.50 | -$2.75 |
AAOI is still losing money, but far less than before: $0.42 per share over the past year, against $4.50 at its worst in late 2024.
CPSH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.00 | +$0.04 |
| Q2 2026 | -$0.01 | +$0.11 |
| Q1 2026 | $0.00 | +$0.20 |
| Q4 2025 | $0.03 | +$0.25 |
| Q3 2025 | -$0.04 | +$0.10 |
| Q2 2025 | -$0.12 | -$0.06 |
| Q1 2025 | -$0.20 | -500% |
| Q4 2024 | -$0.22 | -344% |
CPSH has the edge over AAOI on earnings, with more consistent year-over-year improvement.
AAOI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $269.9M | +127% |
| Q2 2026 | $191.9M | +86% |
| Q1 2026 | $151.1M | +51% |
| Q4 2025 | $134.3M | +34% |
| Q3 2025 | $118.6M | +82% |
| Q2 2025 | $103M | +138% |
| Q1 2025 | $99.9M | +146% |
| Q4 2024 | $100.3M | +66% |
AAOI has the edge over CPSH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +15 points |
| Q2 2026 | -13% | +2.6 points |
| Q1 2026 | -8.6% | +0.3 points |
| Q4 2025 | -8.6% | -2.1 points |
| Q3 2025 | -15% | +10 points |
| Q2 2025 | -16% | +45 points |
| Q1 2025 | -8.9% | +44 points |
| Q4 2024 | -6.5% | +1 points |
AAOI's operating margin was −0.5% last quarter, up 15 points from the same quarter a year ago, near the top of its range since 2019.
CPSH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.9M | +1.1% |
| Q2 2026 | $8.3M | +2.9% |
| Q1 2026 | $7M | -6.4% |
| Q4 2025 | $8.2M | +38% |
| Q3 2025 | $8.8M | +107% |
| Q2 2025 | $8.1M | +61% |
| Q1 2025 | $7.5M | +27% |
| Q4 2024 | $5.9M | -12% |
CPSH's revenue is growing: $9M last quarter, up 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4% | +0.9 points |
| Q2 2026 | -3.1% | -4.8 points |
| Q1 2026 | -7.4% | -9.2 points |
| Q4 2025 | -1.2% | +21 points |
| Q3 2025 | 3.1% | +38 points |
| Q2 2025 | 1.7% | +28 points |
| Q1 2025 | 1.7% | +6.1 points |
| Q4 2024 | -22% | -24 points |
CPSH has the edge over AAOI on profitability, with a higher operating margin.
AAOI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$369.9M | -$291.2M |
| Q2 2026 | -$265.3M | -$174.4M |
| Q1 2026 | -$143.6M | -$64.3M |
| Q4 2025 | -$104.6M | -$51.6M |
| Q3 2025 | -$78.7M | -$58M |
| Q2 2025 | -$91M | -$86M |
| Q1 2025 | -$79.3M | -$45.1M |
| Q4 2024 | -$53M | -$48.4M |
AAOI has burned cash in almost every quarter: −$883M over the past year, against −$302M the year before.
CPSH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$310.2K | -135% |
| Q2 2026 | -$2.4M | -601% |
| Q1 2026 | -$767.8K | +$578K |
| Q4 2025 | -$494.4K | +$974.6K |
| Q3 2025 | $876.8K | +$2.1M |
| Q2 2025 | $476.4K | +$2.1M |
| Q1 2025 | -$1.3M | -$1.2M |
| Q4 2024 | -$1.5M | -3294% |
CPSH has the edge over AAOI on cash flow, with more consistent year-over-year improvement.
AAOI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.7% | +6.3M shares |
| 1 year | +39% | +24.5M shares |
| 3 years | +168% | +55.1M shares |
| 5 years | +224% | +60.7M shares |
| Available history | +340% | +67.9M shares |
AAOI has 88M diluted shares, up 39% from a year ago.
CPSH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.8% | +903K shares |
| 1 year | +35% | +5.1M shares |
| 3 years | +35% | +5.1M shares |
| 5 years | +33% | +4.9M shares |
| Available history | +50% | +6.6M shares |
CPSH has the edge over AAOI on shareholder dilution, with a more favorable share count trend.
AAOI Net Leverage
AAOI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CPSH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -36.2x | Net Cash |
| Q1 2026 | -15.1x | Net Cash |
| Q4 2025 | -4.3x | Net Cash |
| Q1 2024 | -7.1x | Net Cash |
| Q4 2023 | -4.0x | Net Cash |
| Q3 2023 | -3.7x | Net Cash |
| Q2 2023 | -2.9x | Net Cash |
| Q1 2023 | -2.6x | Net Cash |
CPSH has more cash than debt.
AAOI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.1 | Neutral |
| Stochastic | 4.8 | Oversold |
AAOI's weekly RSI is 35 (neutral) and its Stochastic is 5 (oversold).
CPSH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.8 | Neutral |
| Stochastic | 36.9 | Neutral |
CPSH's weekly RSI is 49 (neutral) and its Stochastic is 37 (neutral).
AAOI PE vs Technology Sector
AAOI has no meaningful PE right now: it lost money over the past year.
CPSH PE vs Technology Sector
| Metric | CPSH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CPSH has no meaningful PE right now: it lost money over the past year.
AAOI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.2 | 34% below |
| 20 week MA | $100.6 | 47% below |
| 50 week MA | $100.3 | 47% below |
| 100 week MA | $62.3 | 15% below |
| 200 week MA | $36.9 | 43% above |
AAOI has fallen below most of its moving averages, though it's still 43% above its 200-week average.
CPSH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.72 | 10% above |
| 20 week MA | $4.04 | 1.5% above |
| 50 week MA | $4.51 | 9.1% below |
| 100 week MA | $3.52 | 16% above |
| 200 week MA | $2.89 | 42% above |
CPSH has the edge over AAOI on trend strength, trading above more of its moving averages.
AAOI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.5 | $8.77 | -24% |
| 2021 | $8.77 | $5.64 | -36% |
| 2022 | $5.64 | $1.95 | -65% |
| 2023 | $1.95 | $19.3 | +891% |
| 2024 | $19.3 | $37.7 | +95% |
| 2025 | $37.7 | $37.2 | -1.5% |
| 2026 YTD | $37.2 | $52.9 | +42% |
AAOI has the edge over CPSH on returns for 2026, with the stronger performance.
CPSH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.05 | $2.29 | +118% |
| 2021 | $2.29 | $4.34 | +90% |
| 2022 | $4.34 | $2.75 | -37% |
| 2023 | $2.75 | $2.35 | -15% |
| 2024 | $2.35 | $1.62 | -31% |
| 2025 | $1.62 | $3.21 | +98% |
| 2026 YTD | $3.21 | $4.10 | +28% |
CPSH has finished lower in three of the last six years. It's up 28% so far in 2026.